Off-target lapatinib activity sensitizes colon cancer cells through TRAIL death receptor up-regulation.
Off-target lapatinib activity sensitizes colon cancer cells through TRAIL death receptor up-regulation. Sci Transl Med. 2011 Jun 08; 3(86):86ra50.